AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA1BP | Apolipoprotein A-I binding protein | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ARCN1 | Archain 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ARFIP2 | ADP-ribosylation factor interacting protein 2 | Predicted secreted proteins
| | | | | Expressed in all |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARL8B | ADP-ribosylation factor-like 8B | Predicted secreted proteins
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ARSA | Arylsulfatase A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ARSG | Arylsulfatase G | Predicted secreted proteins
| | | | | Mixed |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ATG5 | Autophagy related 5 | Predicted secreted proteins
| | | | | Expressed in all |
ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Disease related genes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AUH | AU RNA binding protein/enoyl-CoA hydratase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B3GALNT2 | Beta-1,3-N-acetylgalactosaminyltransferase 2 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BCKDHB | Branched chain keto acid dehydrogenase E1, beta polypeptide | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
BGN | Biglycan | Predicted secreted proteins
| | | | | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |